Frederic Oudea to Become Sanofi's Non-Executive Chairman

39
1
Favorite

Frederic Oudea to Become Sanofi's Non-Executive Chairman

Reuters2022-09-05

The appointment of Societe Generale's boss Frederic Oudea as non-executive chairman of Sanofi will be proposed at the next shareholders meeting of the French drugs group, Sanofi said on Monday.

Sanofi made the announcement in a statement appointing Oudea as "Censeur" (non-voting member) of the board with immediate effect.

"The appointment of Frederic Oudea as a director will be submitted for approval at the next Annual General Meeting," the statement said.

"Following this shareholders' meeting, a proposal will be made to the board of directors of Sanofi to appoint Frederic Oudea as non-executive chairman of the board, replacing Serge Weinberg whose term of office will have expired, it said.

Oudea said in May he will leave his position as CEO and director of Societe Generale in May 2023.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（1）

wisley
·2022-09-05
Gg
Reply
1
Report

抱歉，当前请求异常(-1)

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1160451888?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2022-09-05 16:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160451888","market":"us","top_or_hot":-1,"title":"Frederic Oudea to Become Sanofi's Non-Executive Chairman","media":"Reuters","content":"<html><head></head><body><p>The appointment of Societe Generale's boss Frederic Oudea as non-executive chairman of Sanofi will be proposed at the next shareholders meeting of the French drugs group, Sanofi said on Monday.</p><p>Sanofi made the announcement in a statement appointing Oudea as \"Censeur\" (non-voting member) of the board with immediate effect.</p><p>\"The appointment of Frederic Oudea as a director will be submitted for approval at the next Annual General Meeting,\" the statement said.</p><p>\"Following this shareholders' meeting, a proposal will be made to the board of directors of Sanofi to appoint Frederic Oudea as non-executive chairman of the board, replacing Serge Weinberg whose term of office will have expired, it said.</p><p>Oudea said in May he will leave his position as CEO and director of Societe Generale in May 2023.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Frederic Oudea to Become Sanofi's Non-Executive Chairman</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFrederic Oudea to Become Sanofi's Non-Executive Chairman\n</h2>\n<h4 class=\"meta\">\n\n\n2022-09-05 16:31 GMT+8   <a href=\"https://finance.yahoo.com/news/frederic-oudea-become-sanofis-non-082456494.html\"><strong>Reuters</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>The appointment of Societe Generale's boss Frederic Oudea as non-executive chairman of Sanofi will be proposed at the next shareholders meeting of the French drugs group, Sanofi said on Monday.Sanofi ...</p>\n<a href=\"https://finance.yahoo.com/news/frederic-oudea-become-sanofis-non-082456494.html\">Source Link</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SNY","symbol_name":"赛诺菲安万特","start_time":0,"source_url":"https://finance.yahoo.com/news/frederic-oudea-become-sanofis-non-082456494.html","article_id":"1160451888","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160451888","pubTimestamp":1662366668,"columns":[],"sourceInfo":null,"weMediaInfo":null,"summary":"The appointment of Societe Generale's boss Frederic Oudea as non-executive chairman of Sanofi will b","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"SNY":"赛诺菲安万特"},"translate_title":"弗雷德里克·奥迪亚将成为赛诺菲非执行主席","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNY":0.9},"content_text":"The appointment of Societe Generale's boss Frederic Oudea as non-executive chairman of Sanofi will be proposed at the next shareholders meeting of the French drugs group, Sanofi said on Monday.Sanofi made the announcement in a statement appointing Oudea as \"Censeur\" (non-voting member) of the board with immediate effect.\"The appointment of Frederic Oudea as a director will be submitted for approval at the next Annual General Meeting,\" the statement said.\"Following this shareholders' meeting, a proposal will be made to the board of directors of Sanofi to appoint Frederic Oudea as non-executive chairman of the board, replacing Serge Weinberg whose term of office will have expired, it said.Oudea said in May he will leave his position as CEO and director of Societe Generale in May 2023.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9931932763,"gmtCreate":1662379273552,"gmtModify":1676537048562,"author":{"id":"3561443675471397","authorId":"3561443675471397","name":"wisley","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3561443675471397","authorIdStr":"3561443675471397"},"htmlText":"Gg","listText":"Gg","text":"Gg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9931932763","repostId":1160451888,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":39,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}